Vedovati, M. C., Reboldi, G., Agnelli, G., & Verdecchia, P. (2019). Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study. TH Open.
Citação norma ChicagoVedovati, Maria Cristina, Gianpaolo Reboldi, Giancarlo Agnelli, and Paolo Verdecchia. "Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients With Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study." TH Open 2019.
Citação norma MLAVedovati, Maria Cristina, Gianpaolo Reboldi, Giancarlo Agnelli, and Paolo Verdecchia. "Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients With Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study." TH Open 2019.